{"id":"NCT02064439","sponsor":"Bayer","briefTitle":"Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)","officialTitle":"Reduced-dosed Rivaroxaban and Standard-dosed Rivaroxaban Versus ASA in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism in Patients With Symptomatic Deep-vein Thrombosis and/or Pulmonary Embolism","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03-05","primaryCompletion":"2016-09-22","completion":"2016-11-04","firstPosted":"2014-02-17","resultsPosted":"2017-12-19","lastUpdate":"2017-12-19"},"enrollment":3365,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Pulmonary Embolism","Thromboembolism","Thrombosis","Venous Thrombosis","Venous Thromboembolism"],"interventions":[{"type":"DRUG","name":"BAY 59-7939","otherNames":[]},{"type":"DRUG","name":"BAY 59-7939","otherNames":[]},{"type":"DRUG","name":"ASA","otherNames":[]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"},{"label":"Arm 2","type":"EXPERIMENTAL"},{"label":"Arm 3","type":"ACTIVE_COMPARATOR"}],"summary":"This is a multicenter, randomized, double-blind, event-driven, superiority study for efficacy.\n\nPatients with confirmed symptomatic DVT (Deep Vein Thrombosis) or PE (Pulmonary embolism) who completed 6 or 12 months of treatment of anticoagulation are eligible for this trial","primaryOutcome":{"measure":"Number of Participants With the Composite of Fatal or Non-fatal Symptomatic Recurrent Venous Thromboembolism","timeFrame":"Up to 12 months, at least 6 months","effectByArm":[{"arm":"Rivaroxaban (Xarelto, BAY59-7939) 10 mg, OD","deltaMin":13,"sd":null},{"arm":"Rivaroxaban (Xarelto, BAY59-7939) 20 mg, OD","deltaMin":17,"sd":null},{"arm":"Acetylsalicylic (ASA) 100 mg, OD","deltaMin":50,"sd":null}],"pValues":[{"comp":"OG001 vs OG002","p":"0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"0.4328"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":266,"countries":["United States","Australia","Austria","Belgium","Brazil","Canada","China","Czechia","Denmark","France","Germany","Hungary","Israel","Italy","Mexico","Netherlands","New Zealand","Norway","Philippines","Poland","Russia","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom","Vietnam"]},"refs":{"pmids":["25994838","40163217","38844941","35876829","28316279"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":78,"n":1127},"commonTop":["Pruritus","Gastrooesophageal reflux disease","Atrial fibrillation","Dizziness","Rash"]}}